GE Healthcare Technologies Inc. (GEHC)

In the past six months, GEHC's stock has been influenced by Q4 2025 earnings that beat expectations, leading to positive analyst revisions and increased price targets in January and February 2026. In March 2026, the stock experienced a decline due to broader healthcare sector weakness and macroeconomic concerns, but later rebounded amid easing oil prices and a broad market rally. A shareholder alert was issued regarding a 'mini-tender' offer by Potemkin Limited at a price significantly below market value.

GE HealthCare experiences strong demand across its product segments, with a high book-to-bill ratio indicating that demand substantially exceeds the company's ability to fulfill the market. This strong demand is expected to continue long-term, partly driven by an aging global population that will require increased diagnosis and monitoring over time. Specific seasonal fluctuations in the demand for GE HealthCare's products and services were not explicitly detailed.

GE Healthcare Technologies, Inc. (GEHC) is an American health technology company headquartered in Chicago, Illinois, and a leader in the medical device and X-ray machine manufacturing industries. GE HealthCare focuses on precision care, providing integrated solutions, services, and data analytics to enhance hospital efficiency, clinician effectiveness, and patient outcomes. The company's business is structured into four main divisions: Medical Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

GE HealthCare has a significant global presence, serving customers in over 160 countries, with research and development in 18 countries and manufacturing in 20 countries. The United States accounted for 44.4% of total revenue in fiscal year 2025, and China represented 9.8% of total revenue in the same period.

GE HealthCare maintains a strong brand reputation and was named to the 2025 Fortune World's Most Admired Companies™ list. This recognition acknowledged GE HealthCare across various categories, including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets. No specific negative events impacting GE HealthCare's reputation were reported in the past year.

GE HealthCare Technologies Inc. is heavily dominated by institutional owners, who collectively hold more than 85% of the outstanding shares. Major institutional holders include Vanguard Group Inc., BlackRock, Inc., Auto-Owners Insurance Co, Dodge & Cox, Capital Research Global Investors, and State Street Corp. Insiders hold a smaller portion of ownership, typically less than 1%, while public companies and individual investors together hold approximately 13% of the stock.